公司概覽
業務類別 Biotechnology
業務概覽 Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
公司地址 10865 Road to the Cure, Suite 150, San Diego, CA, USA, 92121
電話號碼 +1 858 727-1755
傳真號碼 +1 310 358-3209
公司網頁 https://www.capricor.com
員工數量 160
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Linda Marban, PhD President, Chief Executive Officer and Director 美元 300.00K 10/04/2026
Mr. Anthony J. Bergmann, M.B.A. Chief Financial Officer and Principal Accounting Officer 美元 425.00K 10/04/2026
Ms. Karen G. Krasney, J.D. Executive Vice President and General Counsel 美元 391.77K 10/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. David B. Musket Independent Director 10/04/2026
Dr. Frank Litvack,M.D. Executive Chairman of the Board 10/04/2026
Mr. George W. Dunbar,Jr Independent Director 10/04/2026
Dr. Philip J. Gotwals, PhD Independent Director 10/04/2026
Dr. Linda Marban, PhD President, Chief Executive Officer and Director 10/04/2026
Ms. Karimah Es Sabar Independent Director 10/04/2026
Dr. Paul Gisbert Auwaerter, M.B.A.,M.D. Independent Director 10/04/2026
Mr. Michael Kelliher Independent Director 10/04/2026
 
所屬ETF (更新日期: 07/11/2026 03:24)
代號 名稱 佔比% ▼ 持有日期
UWMProShares Ultra Russell20000.003%30/10/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.002%31/10/2026
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.002%30/10/2026
PWSPacer WealthShield ETF0.001%30/10/2026
RESMColumbia Research Enhanced Small Cap ETF0.0002%31/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%30/10/2026
FESMFidelity Enhanced Small Cap Core ETF0.00001%30/10/2026
DWASInvesco Dorsey Wright SmallCap Momt ETF<0.000001%01/07/2026
FSCCFederated Hermes MDT Small Cap Core ETF<0.000001%16/10/2026
FSEGFidelity Enhanced Small Cap Growth ETF<0.000001%24/08/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF<0.000001%29/06/2026
IWCiShares Micro-Cap ETF<0.000001%26/06/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF<0.000001%08/04/2026
ONEQFidelity Nasdaq Composite ETF<0.000001%18/09/2026
PTHInvesco Dorsey Wright Healthcare MomtETF<0.000001%01/07/2026
QQQXNuveen NASDAQ 100 Dynamic Overwrite<0.000001%30/06/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF<0.000001%03/09/2026
SURISimplify Propel Opportunities ETF<0.000001%31/07/2025
SYZLazard US Systematic Small Cap Eq ETF<0.000001%27/03/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.